KS

Kancherlae Srinivasa Rao

Active Director Additional Director DIN 05227605
DIN 05227605 First appointment Mar 2012 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Kancherlae Srinivasa Rao

Data last updated:

Kancherlae Srinivasa Rao is an Additional Director at Winrex Pharmaceuticals Private Limited (since 2012). The company operates in Pharma.

DIN 05227605
Primary Designation Additional Director
Industry Pharma
First Appointment 14 Mar 2012
Oldest Company Age 30 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director14 Mar 20121996Active

Board colleagues of Kancherlae Srinivasa Rao

NameDINCompanyDesignation
Srinivasa Rao Nannamuri01767752Winrex Pharmaceuticals Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Winrex Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kancherlae Srinivasa Rao

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kancherlae Srinivasa Rao

Kancherlae Srinivasa Rao currently holds 1 directorship: Winrex Pharmaceuticals Private Limited (Additional Director, since 14 Mar 2012).

Kancherlae Srinivasa Rao was first appointed on 14 Mar 2012 as Additional Director at Winrex Pharmaceuticals Private Limited.

The current boards of Kancherlae Srinivasa Rao's companies include Srinivasa Rao Nannamuri (Winrex Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available